
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
MRCK34 | BM&FBovespa | BRL | Delayed | |
MRK | NYSE | USD | Real-time | |
0QAH | London | USD | Real-time | |
MRK | Mexico | MXN | Delayed | |
MRK | Xetra | EUR | Delayed | |
MRK | TradeGate | EUR | Delayed | |
MRK | Frankfurt | EUR | Delayed | |
MRK | Paris | EUR | Real-time | |
MRK | Buenos Aires | ARS | Delayed | |
MRK | Vienna | EUR | Delayed | |
MRK | Lima | USD | Delayed |
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. The company serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. It has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics LP; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.
Name | Age | Since | Title |
---|---|---|---|
Christine E. Seidman | 69 | 2020 | Independent Director |
Patricia F. Russo | 70 | 1995 | Independent Director |
Inge G. Thulin | 68 | 2018 | Independent Director |
Peter C. Wendell | 71 | 2003 | Independent Director |
Stephen L. Mayo | 60 | 2021 | Independent Director |
Thomas Henry Glocer | 63 | 2007 | Independent Lead Director |
Paul B. Rothman | 64 | 2015 | Independent Director |
Pamela J. Craig | 65 | 2015 | Independent Director |
Mary Ellen Coe | 54 | 2019 | Independent Director |
Risa J. Lavizzo-Mourey | 67 | 2020 | Independent Director |
Douglas M. Baker | 63 | 2022 | Independent Director |
Kathy J. Warden | 50 | 2020 | Independent Director |
Robert M. Davis | 55 | 2014 | CEO & Chairman |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review